Jeremy Grantham's BRKR Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 470,701 shares of Bruker Corporation (BRKR) worth $15.29 M, representing 0.04% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in BRKR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 122,689 shares. Largest reduction occurred in Q4 2022, reducing 29,383 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2017 | +10,600 | New Buy | 10,600 | $29.72 |
| Q4 2017 | +8,800 | Add 83.02% | 19,400 | $34.33 |
| Q1 2018 | +69,900 | Add 360.31% | 89,300 | $29.92 |
| Q2 2018 | +12,797 | Add 14.33% | 102,097 | $29.04 |
| Q3 2018 | -7,200 | Reduce 7.05% | 94,897 | $33.45 |
| Q4 2018 | -7,500 | Reduce 7.90% | 87,397 | $29.77 |
| Q1 2019 | -11,200 | Reduce 12.82% | 76,197 | $38.44 |
| Q2 2019 | -17,370 | Reduce 22.80% | 58,827 | $49.94 |
| Q3 2019 | -17,100 | Reduce 29.07% | 41,727 | $43.93 |
| Q4 2019 | -17,002 | Reduce 40.75% | 24,725 | $50.96 |
| Q1 2020 | -225 | Reduce 0.91% | 24,500 | $35.88 |
| Q2 2020 | -24,500 | Sold Out | 24,500 | $0.00 |
| Q3 2022 | +102,879 | New Buy | 102,879 | $53.06 |
| Q4 2022 | -29,383 | Reduce 28.56% | 73,496 | $68.35 |
| Q1 2023 | +44,255 | Add 60.21% | 117,751 | $78.84 |
| Q3 2023 | +28,062 | Add 23.83% | 145,813 | $62.30 |
| Q4 2023 | +58,946 | Add 40.43% | 204,759 | $73.48 |
| Q1 2024 | +60,824 | Add 29.71% | 265,583 | $93.94 |
| Q2 2024 | -265,583 | Sold Out | 265,583 | $0.00 |
| Q1 2025 | +388,272 | New Buy | 388,272 | $41.74 |
| Q2 2025 | +78,035 | Add 20.10% | 466,307 | $41.20 |
| Q3 2025 | +4,394 | Add 0.94% | 470,701 | $32.49 |
Jeremy Grantham's Bruker Corporation Investment FAQs
Jeremy Grantham first purchased Bruker Corporation (BRKR) in Q3 2017, acquiring 10,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Bruker Corporation (BRKR) for 33 quarters since Q3 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to Bruker Corporation (BRKR) was in Q1 2025, adding 388,272 shares worth $16.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 470,701 shares of Bruker Corporation (BRKR), valued at approximately $15.29 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bruker Corporation (BRKR) represents approximately 0.04% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in Bruker Corporation (BRKR) was 470,701 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.